Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive151AccountSocial
MARKETSINVESTLIVE151
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
  1. KPIs

Medtronic cardiovascular growth in Q2


Ends on Tuesday · Nov 24, 6:45am EST

Chance

99%
▲ 3

99%
▲ 3

99%
▲ 14

99%
▲ 14

--%

--%

6 more

$7,947 vol
More Financials Markets

Trending Financials markets

Who will be the next CEO of NVIDIA?S&P price today at 4pm EST?Where will Jensen Huang work next this year?Nasdaq-100 price today at 4pm EST?S&P price range today at 4pm EST?Will the S&P finish positive this year?When will NVIDIA announce its next permanent CEO?(Pyth Index.US30/USD) price on November 19, 2026 at 4pm ET

Financials hub

All Financials markets
Medtronic cardiovascular growth in Q2

Above 8%

Odds
99% chance
Max payout
Mar 31, 2027
$0